Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 1

Interventions

pembrolizumab 1266Specimen Handling 927Magnetic Resonance Spectroscopy 835Carboplatin 825Cyclophosphamide 804Cisplatin 726Nivolumab 666Paclitaxel 630Radiotherapy 609Gemcitabine 571Biopsy 561Bevacizumab 481Dexamethasone 439fludarabine 409Docetaxel 377venetoclax 368Oxaliplatin 364Fluorouracil 356Capecitabine 355atezolizumab 351durvalumab 334Rituximab 332Drug Therapy 325Doxorubicin 317Radiosurgery 315Blood Specimen Collection 310Standard of Care 310Pemetrexed 305Ipilimumab 297Radiation 287

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
G(M1) Ganglioside × 1 year × Clear all
NCT05751668 2026-06-02

Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II)

Alliance for Clinical Trials in Oncology

Phase 2 Suspended
98 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡